Add to Calendar
5/5/2022 8:30:00 AM5/5/2022 8:30:00 PM 2022 State of Possible Conference MassBio's annual State of Possible Conference celebrates how the life sciences make the impossible possible. We will tap today’s brightest minds for engaging conversations on the latest developments in our industry, key insights from the past year, and building a better future for patients around the world. This year's conference will explore the theme "The Massachusetts BioPharma Ecosystem in the Post- Covid Era."
Join MassBio and more than 500 attendees for a day of networking, keynotes, and panel discussions from some of the most inspiring voices in the industry, culminating in a reception celebrating the life sciences community. This is our most popular event so you will want to reserve your spot early.
Royal Sonesta Boston, 40 Edwin Land Blvd Cambridge MA 02142
President and CEO, Repare Therapeutics
Lloyd M. Segal is the President and CEO of Repare Therapeutics (Nasdaq: RPTX), a leading clinical-stage precision oncology company. Prior to Repare, Lloyd was a Managing Partner with Persistence Capital Partners. Lloyd began his career with McKinsey & Company, and subsequently served as CEO of several emerging biotechnology companies including Advanced Bioconcept Inc., Caprion Pharmaceuticals Inc. and Thallion Pharmaceuticals Inc. He currently serves on the board of directors of GBC American Fund. Lloyd previously served as Chairman of LMC Diabetes & Endocrinology, and was Chairman of the Board of MedReleaf (TMX:LEAF), which was sold to Aurora Cannabis for $3.2 billion in 2018. He served as Entrepreneur-in-Residence with Versant Ventures from 2016 to 2020. Lloyd was honored in 2013 by the Financial Times as Outstanding Director of the Year for public companies. Lloyd holds a B.A. in politics from Brandeis University and an M.B.A. from Harvard Business School.